Welcome to the new Independent website. We hope you enjoy it and we value your feedback. Please contact us here.

Business News

Glaxo to sell Ribena and Lucozade

GlaxoSmithKline has confirmed that it will sell the drinks brands Lucozade and Ribena in a deal that could raise more than £1bn.

Sir Andrew Witty, the chief executive, said: "These iconic brands, particularly outside the 'core' Western markets, could be better leveraged by companies with existing category presence and infrastructure in these regions."

The drinks brands – which have sales of about £600m, mainly in the UK – are expected to attract interest from private equity and trade buyers. During the first three months of this year, Ribena sales grew 2 per cent but Lucozade was down 2 per cent.

GSK's sales in the first quarter fell 3 per cent to £6.47bn as key drugs fell out of patent.